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Abstract
Background: A valuable tool for both research and industry, in vitro fertilization (IVF) has applications range from
gamete selection and preservation of traits to cloning. Although IVF has achieved worldwide use, with
approximately 339,685 bovine embryos transferred in 2010 alone, there are still continuing difficulties with
efficiency. It is rare to have more than 40% of fertilized in vitro cattle oocytes reach blastocyst stage by day 8 of
culture, and pregnancy rates are reported as less than 45% for in vitro produced embryos. To investigate potential
influences in-vitro fertilization (IVF) has on embryonic development, this study compares in vivo- and in vitro-
derived bovine blastocysts at a similar stage and quality grade (expanded, excellent quality) to determine the
degree of transcriptomic variation beyond morphology using RNA-Seq.
Results: A total of 26,906,451 and 38,184,547 fragments were sequenced for in vitro and in vivo embryo pools,
respectively. We detected expression for a total of 17,634 genes, with 793 genes showing differential expression
between the two embryo populations with false discovery rate (FDR) < 0.05. There were also 395 novel transcribed
units found, of which 45 were differentially expressed (FDR < 0.05). In addition, 4,800 genes showed evidence of
alternative splicing, with 873 genes displaying differential alternative splicing between the two pools (FDR < 0.05). Using
GO enrichment analysis, multiple biological pathways were found to be significantly enriched for differentially
expressed genes (FDR < 0.01), including cholesterol and sterol synthesis, system development, and cell differentiation.
Conclusions: Thus, our results support that IVF may influence at the transcriptomic level and that morphology is
limited in full characterization of bovine preimplantation embryos.
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Background
The use of in vitro fertilization (IVF) in cattle and in
other species such as humans has seen rapid increases
in the last few decades. In 2010 alone, over 339,685 in
vitro-produced bovine embryos were transferred world-
wide [1]. In addition 60,190 infants were born in the
United States in 2009 from assisted reproductive tech-
nologies (ART), 99% of which involved IVF [2]. In addi-
tion, the International Committee for Monitoring
Assisted Reproductive Technology’s( I C M A R T )
estimated that in 2003, approximately 232,000 babies
had been born by ART worldwide [3].
Although the statistics reflect a striking amount of IVF
use, they also depict relatively low success rates. It is rare
to have more than 40% of fertilized in vitro cattle oocytes
reach blastocyst stage, and of those transferred pregnancy
rates are less than 45% for in vitro techniques [4]. Similarly
in humans, statistics from 2007 show an approximate
32-37% live birth rate from transfers [2]. As such, there is
increasing pressure to better understand the embryo’sb i o -
logical framework in order to interpret the seemingly low
developmental rates. The reported sensitivity of the embryo
to environmental factors, such as pH and ionic stress dur-
ing the period in which they are manipulated for in-vitro
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depth studies [5].
Morphologically, distinction between in vivo and IVF
pre-implantation embryos have been confirmed by char-
acteristics such as differing cytoplasmic color [6], lipid
droplet composition [7], and mitochondrial content [8].
A comparison of in vitro and in vivo blastocysts via light
microscopy showed lower microvilli coverage and lipid
content in the in vitro-produced embryos [9]. In addition
to morphology, previous studies have ascertained differ-
ences metabolically [10] and at the chromosomal level,
with in vitro embryos incurring higher incidences of
abnormalities such as mixiploidy [11].
Differential gene expression has gained increasing
attention as a mechanism underlying the phenotypic
abnormalities between in vivo and in vitro embryos
[9,12-15]. In addition to cattle, these differences have also
been reported in sheep [16] and mice [17], suggesting
that the IVF process itself may influence the biological
framework of the early developing embryo. These studies,
however, utilized expression microarrays, which provide
limited transcriptomic data. In addition, in vivo embryos
were derived from a limited number of super-ovulated
donor cows, which presents a confounding variable of
potential superovulation effects. In contrast, this study
utilizes in vivo embryos from non-superovulated cows to
eliminate potential sources of transcriptomic influence to
characterize transcriptomic variations due to the in vitro
process itself. We hypothesize that in vivo and in vitro
embryo populations differ in their biological and tran-
scriptomic characteristics and that the identification of
these differences can assist in understanding the molecu-
lar mechanisms influencing development of IVF embryos.
This study reports a fine scale assessment of the differen-
tial gene expression and alternative splicing between
bovine in vivo- and in vitro-derived embryos to provide
potential transcriptomic characteristics for further
investigation.
Results
Deep sequencing of the bovine blastocyst transcriptomes
U s i n gR N A - S e q ,t h i ss t u d yw a sa b l et oc h a r a c t e r i z et h e
transcriptomic landscapes of in vivo- versus in vitro-derived
bovine blastocysts. In order to accomplish this, two rounds
of linear amplification of mRNA were used to ensure that
individual embryos produced enough RNA input for analy-
sis. Amplified RNA from five individual in vitro-derived
and five in vivo-derived embryos all with the same sire was
pooled, multiplexed, and sequenced on the HiSeq2000,
producing approximately 60 million pair-end reads of 100
bp in length. Table 1 displays the overall results of sequen-
cing read alignments to the bovine reference genome.
Analysis of sequencing reads was done using Tophat
software [18] for alignment with the reference genome
(btau4.0). Of the total sequenced fragments, 83% and 85%
were mapped to the reference genome for in vitro and in
vivo embryos, respectively, and of these, 91% and 92%,
respectively, were uniquely mapped to specific regions in
the bovine genome (Table 1). Of those uniquely mapped,
19,556,926 and 28,326,794 were mapped to one of the
autosomes or X chromosome for in vitro and in vivo
embryos, respectively (Table 1).
Identification and analysis of novel transcribed units
Using stringent criteria, our analysis uncovered a total of
395 novel transcribed units. Of these, 45 show differential
expression (FDR < 0.05), with 23 transcripts over-
expressed in the in vivo embryos and 22 over-expressed in
the in vitro embryos. Three transcripts had exclusive
expression in the in vivo population while one transcript
was exclusive to in vitro-produced embryos. When com-
pared to known cattle ESTs from the UCSC genome
browser [19], we found that 237 novel transcripts were
supported by at least five cow ESTs with total coverage
greater than 50%. Twenty of these transcripts showed sig-
nificant differential expression.
Identification and validation of differentially expressed
genes
The RNA-Seq technique allows analysis of the differential
expression profile via transcript abundance with a high
sensitivity for lowly expressed transcripts that would
otherwise be undetected by standard microarrays [20].
Overall we tested 17,634 genes for expression analysis,
with 793 genes showing differential expression between in
vitro and in vivo embryos (FDR < 0.05). Of these, 37 genes
Table 1 Summary of sequence read alignments to the reference genome
Sample In vitro embryos In vivo embryos
Pair end reads 26,906,451 x 2 38,184,547 x2
Total sequenced fragments 26,906,451 38,184,547
Total mapped fragments 22,428,488 32,384,577
Uniquely mapped fragments 20,389,330 29,728,363
Fragments mapped to autosomes and X chromosome 19,556,926 28,362,794
Fragments mapped to annotated genes 13,304,981 16,976,922
Fragments mapped to annotated exons 6,942,761 8,185,094
Fragments overlapped with annotated introns 6,362,220 8,791,828
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10 genes were exclusively expressed in the in vitro popula-
tion. Of the remaining 746 genes, 549 showed higher
expression in the in vivo embryos versus 197 genes that
showed higher expression in the in vitro embryos. Table 2
shows the breakdown of fold-change among the differen-
tially expressed genes between the two populations.
For the validation of RNA-Seq results, four genes
showing high levels of significance (CFL1, MYL7, DUS6,
and B4GALT4) were selected and normalized to GBG5
v i aq R T - P C Ri nt h ei n d i v i d u a le m b r y oa R N As a m p l e s .
Two genes, CFL1 and MYL7, showed higher expression
in the in vitro embryos with an average of 79.5- and 25.5-
fold differences, respectively, when measured with qRT-
PCR and 18- and 60-fold differences, respectively, using
RNA-Seq (Figure 1). The other two genes, DUS6 and
B4GALT4, showed higher expression in the in vivo
embryos, with an average of 15- and 4.6-fold differences,
respectively using qRT-PCR and 21- and 18-fold differ-
ence, respectively, with RNA-Seq (Figure 1). Thus, these
four genes showed similar patterns of mRNA abundance
in RNA-Seq analysis and qRT-PCR.
Differential alternative splicing between in vivo and in
vitro embryos
In all, we detected a total of 4,800 genes expressing more
than one splice variant. For further analysis, we used genes
that had multiple isoforms and had a single transcription
start site (n = 2,457 genes). Of these, 873 showed differen-
tial alternative splicing between the two embryo popula-
tions (FDR < 0.05). Moreover, following Wang et al. [21],
2,329 isoforms from 1,493 genes were classified into a
total of 2,778 simple alternative events that fell into six dif-
ferent categories (Table 3). It is important to remark that
some genes showed more than one variable splicing event.
The rest of the genes (n = 964) showed more complicated
alternative splicing events and it was not possible to clas-
sify the events into these simple six categories.
Validation of alternative splicing was confirmed for the
genes AP2B1 and ZDHHC16. Both of these genes showed
evidence for single exon skipping. As such, primers were
designed around this region to confirm the splicing
event. The first primer set for AP2B1 had exon inclusion
and produced a 134-bp product in comparison to the
second primer set excluding the exon which resulted in a
92-bp product (Figure 2). For ZDHHC16,t w op r i m e r s
sets were also created, with the first set producing a
97-bp product (transcript that excludes the exon) and the
second set producing a 118-bp product that included the
skipped exon (Figure 2). Since both transcripts were pre-
sent in both embryo samples for each gene, although dif-
fering in ratio, they were tested in a pool each of in vivo
and in vitro embryo cDNA for validation. Overall, RNA-
Seq results for alternative splicing were also validated.
Gene ontology analysis
To gain insights into the biological processes that could
be regulated differently between in vivo and in vitro
embryos, we performed a GO analysis. We found a total
of 23 pathways significantly enriched (FDR < 0.01) for
differentially expressed genes, many of which are related
to developmental processes (Additional file 1). The
pathway showing the highest level of significance was
cholesterol biosynthesis. Eleven genes involved in this
pathway showed higher expression in the in vitro
embryos compared to the in vivo embryos (Table 4).
Furthermore, after cholesterol biosynthesis, the pathways
of system development, sterol synthesis, and cell differ-
entiation showed the highest significance in the GO
analysis (Additional file 1).
Discussion
Depth of RNA-Seq analysis
Our current knowledge on dynamic changes in gene
expression during embryonic development has for the
most part been based on results from microarray tech-
nology. Although providing insight, microarrays are
based on a priori knowledge and oligonucleotide design
and may not detect lowly expressed transcripts or pro-
vide complete genome coverage due to lack of probe
availability. Also, expression microarrays do not provide
information regarding alternative splicing and novel tran-
scripts. Therefore, we utilized RNA-Seq technology in
this study to perform an in-depth analysis of the tran-
scriptomic landscape of bovine in vivo- and IVF-derived
embryos at the blastocyst stage. This is the first report of
a high-resolution snapshot of transcriptomic differences
between in vivo and in vitro embryos beyond expression
for any species using RNA-Seq technology.
Another strength of RNA-Seq technology is the ability
to improve genome annotation by the discovery of novel
transcripts. In our study, we identified 307,646 bp covering
Table 2 Fold change differences in expression of genes differentially expressed between in vivo and in vitro embryos
at FDR < 0.05
Fold change
≤ 5 5-10 10-15 15-20 > 20
Genes over-expressed in in vivo embryos 132 108 93 55 161
Genes over-expressed in in vitro embryos 51 42 34 19 51
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these, 45 transcripts showed differential expression
between in vivo and in vitro embryos (FDR < 0.05), with
23 expressed higher in the in vivo embryos and 22 in the
in vitro embryos. In addition, three novel transcripts were
exclusive to the in vivo embryos and one to the in vitro.
Thus, this is evidence that not only are there uncharacter-
ized regions of the bovine genome, but also that these
novel regions may serve important biological roles.
Beyond morphology
Although the two embryo groups possessed similar mor-
phological appearance and would have received a similar
rating for developmental stage and embryo quality, they
possessed numerous transcriptomic differences. Of the
793 genes showing differential expression, 413 had greater
than a 10-fold difference in mRNA concentrations.
In addition, RNA-Seq technology provided valuable
information regarding alternative and novel splice variants
reflecting more complex mechanisms of RNA regulation.
A recent study by Corcoran et al. [13] found that many
genes involved in RNA processing and translation were
differentially expressed between in vivo and in vitro blasto-
cyst populations. Our study extends these observations by
identifying a number of alternatively spliced genes
between in vivo and in vitro populations.
Overall, our study detected 873 genes with alternative
splicing, and of these, 782 showed differential splicing
without showing overall differential gene expression. This
is critical as alternative splicing can influence protein pro-
duction and biological function. Associations between dif-
ferential alternative splicing and embryonic development
have been reported by Zhang et al. [22]. This study
reported differential expression levels of alternative tran-
scripts for heat shock proteins in developmentally arrested
in vitro bovine embryos in comparison to developed blas-
tocysts, with the suggestion that differential processing of
RNA is associated with regulation of embryonic develop-
ment. Thus, our study is presenting transcriptomic infor-
mation that would otherwise not be detected by standard
microarray and yet have key biological importance for
development.
Beyond individual gene differences, our study also
revealed several biological pathways that were significantly
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Figure 1 Comparison of changes in four differentially expressed genes from the RNA-Seq results (light grey) vs. qRT-PCR (dark grey).
Bars above the X-axis denote genes with higher expression in the in vitro embryos while bars below the X-axis denote genes with higher
expression in the in vivo embryos.
Table 3 Classification of genes with simple alternative splicing events or differential alternative splicing
Alternative splicing event No. of events No. of genes No. of genes that showed differential splicing*
Exon skipping 1147 684 276
Alternative 5’ 551 344 142
Alternative 3’ 353 265 121
Intron retention 404 264 106
Mutually exclusive 62 53 21
Alternative last exon 261 181 66
*Differential alternative splicing between in vivo- and in vitro-derived embryos
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embryonic mRNA concentrations. The 23 pathways show-
ing the highest level of significance can be found in Addi-
tional file 1.
Of particular interest was the cholesterol biosynthesis
pathway, which had 11 genes with increased expression
in the in vitro embryos. Differential expression levels of
the cholesterol biosynthesis pathway between our embryo
populations could be supported by a study conducted by
Tint et al. establishing that the mother provides neces-
sary cholesterol to the in vivo embryo throughout the
pre-implantation period [23]. Since in vitro embryos lack
contact with maternal tissues, and thus maternal sources
of cholesterol, there could be increased de novo produc-
tion of cholesterol.
Of the differential genes listed in Table 4, many have
been shown to be critical to the cholesterol biosynthesis
process. For example, lanosterol synthase (LSS) catalyzes
(S)-2,3 oxidosqualene into the parental compounds for
cholesterol and ultimate steroid synthesis in mammals
[24]. In addition, the gene HMGCR contributes to the
major rate-limiting step for conversion of HMG-CoA
into mevalonate [25]. HMGCR is also regulated through
a feedback system, which could be altered by a lack of
maternal influence and delivery on the embryo [25].
Should the proper levels of these genes be perturbed, it
could have significant effects on an organism by altering
products of cholesterol (i.e. steroids). Interestingly it
should be noted that another pathway related to steroid
production (sterol biosynthesis) was also enriched
between in vivo and in vitro embryos.
In addition, the cell differentiation pathway was enriched
which is intriguing as differentiation is not only critical for
the blastocyst formation but to ensure proper implantation
and placenta development [26]. This finding supports ear-
lier histological studies showing fewer ICM cells in in
vitro-produced bovine embryos compared to in vivo [27].
Detection of this differential pathway in our study provides
further evidence for its potential importance, thus helping
to further the ongoing characterization of in vivo and in
vitro embryos. In conclusion, our results suggest that IVF
may influence at a larger scale by altering biological path-
ways critical for early development.
Potential limitations
One limitation to this study is the potential shortening of
reads due to the RNA amplification process, which tends
to favor the 3’ end of the sequence. In addition this may
cause a lack of complete information on full length alter-
native splicing. Due to limited amounts of RNA in indivi-
dual embryos, two rounds of linear amplification were
necessary. Although it remains unclear as to the degree
of transcript shortening that occurs, it should be
acknowledged as it may prevent construction of full
length transcripts as discussed by Huang and Khatib [28].
Nonetheless, amplification provided a means to utilize
individual embryos for validation and pool construction.
A second limitation to this study was the lack of RNA-
Seq replicates. Nonetheless, in a prior RNA-Seq study by
our lab, two pools were utilized and results were consis-
tent with qRT-PCR validations and prior microarray
results that used replicates [28]. Thus, even with limited
number of samples, RNA-Seq results from this study
provide valuable insight into the genomic characteristics
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Figure 2 Alternative splicing validations for two genes using PCR with cDNA as the template. Lanes A and B correspond to the two
fragment sizes for the gene AP2B1 (134 and 92 bp) while G and H represent the two transcripts for ZDHHC16 (97 and 118 bp). Lanes C and I
are positive controls (GBG5, 115 bp) while D, E, F, J, K, and L are negative controls.
Table 4 Fold difference and q-values of 11 cholesterol
biosynthesis pathway genes
Gene ID Gene Name Fold change q-value
ENSBTAG00000011839 HMGCS1 5.10 < 0.001
ENSBTAG00000007840 HMGCR 3.85 < 0.001
ENSBTAG00000017819 PMVK 9.51 < 0.001
ENSBTAG00000012059 MVD 2.62 0.047
ENSBTAG00000004075 IDI1 3.83 0.002
ENSBTAG00000012432 FDFT1 3.32 0.012
ENSBTAG00000005498 SQLE 3.34 0.004
ENSBTAG00000018936 LSS 7.75 < 0.001
ENSBTAG00000001992 CYP51 5.93 < 0.001
ENSBTAG00000003068 SC4MOL 2.53 0.036
ENSBTAG00000016465 DHCR7 4.68 < 0.001
All listed genes showed higher expression in the in vitro embryos
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acknowledged limitations, using RNA-Seq approach as a
hypothesis-generating study provides numerous opportu-
nities for further investigation to better understand early
embryonic development.
Conclusions
Use of IVF and in vitro embryo culture has been found to
be a valuable tool for both research and industry with
applications ranging from infertility treatment, and
gamete selection to cloning. In addition, the bovine
embryo model has become an interesting and popular
biological model to help in understanding potential pro-
blems or optimization procedures for human embryonic
practices [29]. As such, results of this study may help elu-
cidate the molecular mechanisms leading to seemingly
low success rates of IVF embryos and may help to unlock
important factors underlying the early embryo’sg r o w t h
and sensitivity during the pre-implantation period. Over-
all, our results support the initial hypothesis that in vitro
embryos differ from their in vivo counterparts on multi-
ple transcriptomic levels. In addition, this study high-
lighted the importance of studying RNA processing
beyond the levels of expression and the limitations mor-
phology alone has on embryo characterization. Candidate
genes and pathways uncovered in this study can be pur-
sued in future studies with the goal of improvement of in
vitro fertilization and culture systems and to further our
understanding of factors involved in optimal embryonic
development.
Methods
In vivo embryo collection and grading
In vivo embryos were collected from non-superovulated
lactating Holstein cows (n = 84, multiparous; approximately
77 days after calving) at the University of Wisconsin-Madi-
son. To allow a synchronous follicular development and
tight regulation of ovulatory follicle size and time of ovula-
tion, cows were synchronized with the Double OvSynch
protocol similar to that described in Souza et al. [30]. Most
cows have single ovulation after this protocol and exhibit
excellent fertility for lactating dairy cows [30]. Cows were
artificially inseminated with semen from one of three high-
fertility bulls. The use of a large number of cows and three
bulls was to ensure an adequate number of excellent quality
embryos produced from a single sire. Cows were evaluated
using ultrasonography to determine where ovulation
occurred, and seven days post-insemination, the ipsilateral
horn(s) underwent a non-surgical uterine horn flushing for
embryo recovery as described in Hackbart et al. [31].
Embryos were then graded for embryo quality (1 = excel-
lent or good, 2 = fair, 3 = poor, and 4 = degenerate) and
embryo stage (1 = 1-cell, 2 = 2-16 cell, 3 = early morula,
4 = compacting morula, 5 = early blastocyst, 6 = blastocyst,
7 = expanded blastocyst, 8 = hatched blastocyst) according
to International Embryo Transfer Society (IETS) standards
[32]. For the purpose of this study, we collected blastocyst
stage embryos that were expanded and with excellent qual-
ity (Figure 3). Upon collection, embryos were placed in
RNALater (Ambion, TX) to preserve RNA integrity and
frozen at -20°C until RNA extraction.
In vitro maturation, fertilization, and embryo culture
Ovaries from Holstein cows were obtained from a local
abattoir, and from them antral follicles (2-6 mm) were
aspirated. Recovered oocytes were then washed with warm
Tyrode’s albumin lactate pyruvate (TALP)-Hepes and
underwent maturation, fertilization, and culture as out-
l i n e di nd e t a i lb yK h a t i be ta l .[ 3 3 ]a n db r i e f l yh e r e .F o r
fertilization, frozen-thawed semen from one bull used in
producing the in vivo embryos was prepared by centrifu-
ging through a discontinuous Percoll gradient (45-90%) to
recover motile sperm and adjusted to a final concentration
of 1 × 10
6/ml [34]. After 8 days of culture, embryos were
morphologically assessed and those with an IETS grading
of 7-1 (expanded blastocyst, excellent quality) were col-
lected individually in RNALater (Ambion) and frozen at
-20°C until RNA extraction (Figure 3).
RNA extraction, amplification, and pooling
Total RNA was extracted from individual embryos using
RNaqueous Micro (Ambion). Due to limitations in the
amount of RNA in each embryo, linear amplification was
performed using the MessageAmp II aRNA amplification
kit (Ambion). Briefly, cDNA was primed by a T7 promoter
tagged poly-dT primer. After the second strand synthesis,
the double stranded cDNA was used as template in an in
vitro transcription reaction using T7 polymerase with
unlabeled NTPs. Two rounds of linear amplification pro-
vided a proper concentration of RNA for analysis. In order
to minimize biological variance between the in vivo and in
vitro embryo groups for the transcriptomic comparisons,
five grade 7-1 embryos from each group from the same
sire were used. Samples of the amplified RNA from
 
Figure 3 Morphological assessment of embryos at the
blastocyst stage with a grade of 7-1 according to IETS
standards. A = in vivo blastocyst; B = in vitro blastocyst.
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prepped for RNA-sequencing.
RNA sequencing
Libraries of amplified RNA for each pool were prepared
following the Illumina mRNA-Seq protocol. Sequencing
libraries were created from 50 ng samples and
sequenced with Illumina’s HiSeq 2000 at the University
of Wisconsin-Madison Biotechnology Center. Libraries
were barcoded, multiplexed, and sequenced in one
HiSeq 2000 lane. A ‘fragment’ was defined as a cDNA
fragment sequenced from both ends. Approximately 60
million fragments were sequenced for both libraries and
de-multiplexed.
Mapping reads to the reference genome
Sequencing reads were mapped to the reference genome
(btau4.0) using the software package Tophat (v1.2.0) [18]
implemented on Galaxy [35]. The alignment was first
performed in each of the samples independently. Novel
splice junctions discovered by Tophat and known splice
junctions from the Ensembl annotation were then com-
bined and supplied to Tophat for a second alignment
such that the junction database was the same for each
sample. This mapping strategy allows a full utilization of
the novel junctions identified in both samples. A maxi-
mum of two mismatches and a minimum length of 25 bp
per segment were allowed. Moreover, reads that mapped
equally well to more than 40 genomic locations were
discarded.
Assembly of transcripts and estimation of abundance
Cufflinks (v1.0.3) was used to assemble transcript models
from RNA-Seq alignments and to estimate transcript and
gene expression [36]. This program uses graph theory to
find a parsimonious set of transcript models that comply
with alignments. In addition, it estimates isoform and gene
expression (fragments per kilobase exon per million
mapped fragments, or FPKM) by optimizing a likelihood
function containing transcript abundances as parameters.
In our analysis, abundances of transcripts were upper-
quartile normalized and also corrected for sequence bias
in order to improve expression estimates [37].
Identification of novel transcribed units
Novel transcribed units were defined as regions contain-
ing multi-exonic transcripts that were: 1) at least 1,000
bp away from known gene boundaries; 2) of length ≥
250 bp; 3) with an average coverage ≥ 5; 4) with less
than 50% of repetitive sequences; and 5) with splice
junctions supported by at least two junction alignments.
For external support of our novel transcripts, cow EST
alignments were downloaded from the UCSC genome
browser and compared to the novel transcribed units
using BEDTools [38].
Overall gene expression and GO enrichment analysis
Differential expression of annotated genes and novel
transcribed units was tested using Cuffdiff, a program
part of the Cufflinks package for testing differential gene
expression [35]. In our study, genes with a false discovery
rate (FDR) < 0.05 were considered significant. FDR is
defined as the expected proportion of false positives
among all significant hypotheses [39]. The Gene Ontol-
ogy (GO) enrichment analysis was performed using the
GOseq (v1.4.0) package [40] that is available in the R lan-
guage/environment [41]. Importantly, GOseq adjusts for
gene selection bias due to difference in gene lengths,
which is known to affect the variance of gene expression
estimates [40]. Biological pathways with a FDR < 0.01
were considered significant.
Analysis of alternative splicing
Differential alternative splicing of genes that showed more
than one isoform was tested also with Cuffdiff using the
Shannon-Jensen divergence metric to measure relative
abundances between transcripts [37]. A FDR < 0.05 was
chosen as the significance threshold for detecting differen-
tial alternative splicing between the two treatment groups.
Alternative splicing events were classified according to
Wang et al. [21] using a custom perl script.
Validation of RNA-Seq data
For alternative splicing validation, PCR was done using
cDNA produced from in vivo and in vitro embryo pools.
Primers were designed for two genes (AP2B1 and
ZDHHC16) that had exon-skipping events (Table 5).
Fragment sizes differentiated the two transcripts for each
gene. Quantitative real-time PCR (qRT-PCR) was used to
validate differential expression of a select number of
genes. A preliminary analysis was done to establish
proper housekeeping genes for normalization as described
in Vandesompele et al. [42]. Briefly, this method assumes
that the ratio of two internal control genes is uniform
across samples, regardless of the cell type or environmen-
tal condition. The control gene producing the smallest
relative stability value M (the average of the pair-wise
variation when compared with the other control genes) is
deemed as having the most stable expression across sam-
ples, assuming no co-regulation, and is thus chosen for
normalization. The genes guanine nucleotide binding
protein (G protein) gamma 5 (GBG5), phosphoglycolate
phosphatase (PGP), and cytochrome b5 type B (QOP5F6),
showed moderate and relatively constant expression
across samples in the RNA-Seq data and thus were
selected as candidate housekeeping genes. Of these,
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and was designated as the internal control. Four differen-
tially expressed genes with the highest significance [myo-
sin light chain 7-regulatory (MYL7), Dual specificity
protein phosphatase 6 (DUS6), cofilin 1 (non-muscle)
(CFL1), and UDP-Gal:betaGlcNAc beta 1,4- galactosyl-
transferase, polypeptide 4 (B4GALT4)] were chosen for
validation. Expression was measured in the five individual
embryo samples composing the pools, averaged, and
compared to RNA-Seq results. Primers for validation
were designed to cross exon-exon junctions and are
shown in Table 5. The relative gene expression values
were calculated using the 2
-ΔΔCt method [43].
Additional material
Additional file 1: The most significant biological GO pathways
detected (FDR < 0.01) for differentially expressed genes. Pathways
are ranked in order of decreasing statistical significance.
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